doi: 10.3760/cma.j.issn.1007-3418.2010.06.019.
[Preventive effect of entecavir on hepatitis B flare up in HBsAg(+) breast cancer patients receiving chemotherapy]
[Article in
Chinese]
Affiliations
- PMID: 20587323
- DOI: 10.3760/cma.j.issn.1007-3418.2010.06.019
Item in Clipboard
[Preventive effect of entecavir on hepatitis B flare up in HBsAg(+) breast cancer patients receiving chemotherapy]
[Article in
Chinese]
Zhonghua Gan Zang Bing Za Zhi.
2010 Jun.
No abstract available
Similar articles
-
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.J Viral Hepat. 2010 Jan;17(1):16-22. doi: 10.1111/j.1365-2893.2009.01146.x. Epub 2009 Jul 19. J Viral Hepat. 2010. PMID: 19622117 Clinical Trial.
-
Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?Breast Cancer Res Treat. 2005 Jul;92(1):95-6. doi: 10.1007/s10549-005-1942-y. Breast Cancer Res Treat. 2005. PMID: 15980997 No abstract available.
-
Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series.Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):551-4. Eur Rev Med Pharmacol Sci. 2010. PMID: 20712263
-
[Entecavir. Treatment of chronic hepatitis b virus infections].Med Monatsschr Pharm. 2006 Nov;29(11):392-6. Med Monatsschr Pharm. 2006. PMID: 17131685 Review. German. No abstract available.
-
[Entecavir - options and obstacles of an effective treatment for chronic hepatitis B].Dtsch Med Wochenschr. 2010 Jan;135(1-2):32-7. doi: 10.1055/s-0029-1244814. Epub 2009 Dec 18. Dtsch Med Wochenschr. 2010. PMID: 20024882 Review. German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
